Ancel·la Santos

@[email protected]
69 Followers
116 Following
133 Posts
Interested in #AccessToMedicines #PharmaRegulation #EU #Politics. Working at @beuc. Studying #psychology in my free time. My views.
Ancel·la SantosApr 13, 2023
The Consumer VoiceApr 11, 2023
Are pharmaceutical companies putting profits before patients? Join us for a screening of 'Drug Shortages - Profits Before Patients' and a panel debate featuring journalist Rozenn Le Saint, MEP @woelken , @beuc's Monique Goyens, and Medicines for Europe 's Adrian van den Hoven. https://www.beuc.eu/events/drug-shortages-profits-patients-screening-arte-documentary-debate-eus-pharma-legislation
Drug Shortages – Profits Before Patients: A Screening of the ARTE Documentary & Debate on the EU’s Pharma Legislation

In 2022, the Franco-German channel ARTE broadcast the results of an international investigation by film company Découpages which looked at how pharmaceutical companies are putting profits before patients and benefitting from shortages of medicines in some areas to raise their prices.

BEUC
Ancel·la SantosMar 25, 2023
James Packard LoveMar 21, 2023

Pretty disappointed in this:

------
HHS and NIH reject the Xtandi March-in petition

https://www.keionline.org/38536

HHS and NIH reject the Xtandi March-in petition - Knowledge Ecology International

NIH-rejection-Xtandi-marchin-12march2023 This is an appalling decision. The worst is this quote: “practical application is evidenced by the “manufacture, practice, and operation” of the invention and the invention’s “availability to and use by the public….” This is what 35 USC 201(f)… Continue Reading →

Knowledge Ecology International
Ancel·la SantosMar 20, 2023
Will PhoenixMar 20, 2023
Snowdonia from Traeth Llanddwyn #photography #Landscape #Wales
Ancel·la SantosMar 20, 2023
IQWiGMar 2, 2023

📣 New #BMJ paper 📭 with colleagues from #KCE 🇧🇪, https://twitter.com/KCEfgov

Is replacing randomized controlled trials #RCTs 🎲 ⚖️ with real-world data #RWD 👩‍⚕️ 🗒️ for regulatory decisions a self-fullfilling prophecy?

How does the enthusiasm for observational data from routine practice affect the availability of robust #evidence 🔎 for decision making in our health care systems? 🏥

As a brief introduction to the topic, read our #thread of 8 posts 🧵

https://www.bmj.com/content/380/bmj-2022-073100

KCE (@KCEfgov) / Twitter

Federaal Kenniscentrum voor de Gezondheidszorg-Centre Fédéral d'Expertise des Soins de Santé-Belgian Health Care Knowledge Centre

Twitter
Ancel·la SantosMar 20, 2023
Show threadIQWiGMar 2, 2023

8/8

#EMA and #HTA bodies together should ensure pre-registration platform trials meet regulatory and HTA requirements.

Giving EMA a mandate to initiate these trials can support drugs development in small populations more efficiently than turning to non-randomised studies.

-
EDIT 📣

Our press release has just been published: https://www.iqwig.de/en/presse/press-releases/press-releases-detailpage_89728.html

Efficient RCTs with real world data for benefit assessments of drugs: accelerating evidence-based care

Together with authors from the Belgian HTA agency KCE, three IQWiG authors argue in the BMJ for efficiently planned and conducted RCTs, even in supposedly difficult areas.

IQWiG
Ancel·la SantosMar 8, 2023
James GleickMar 8, 2023

“Better to talk to people than communicate by tweet.”

The former tech giant known as Twitter has a new company motto.

Ancel·la SantosFeb 26, 2023
Martin PoschFeb 2, 2023
Implementing clinical trial data sharing requires training a new generation of biomedical researchers.
Comment in
@NatureMedicine:
https://rdcu.be/c4JeR led by U. Mansmann @NaudetFlorian
Ancel·la SantosFeb 3, 2023
EURACTIV HealthJan 27, 2023
Council hashes out secondary use of data in EU health data space https://ift.tt/fdRV4rQ
Council hashes out secondary use of data in EU health data space

The EU Council has found common ground on the secondary use of data, one of the most crucial aspects for gaini

EURACTIV
Ancel·la SantosJan 21, 2023
Matthew RimmerJan 20, 2023
Consumer watchdog calls on public to report social media influencers failing to disclose posts as ads https://www.theguardian.com/australia-news/2023/jan/20/consumer-watchdog-calls-on-public-to-report-social-media-influencers-failing-to-disclose-posts-as-ads #advertising #consumerlaw #influencers #auslaw #auspol
Consumer watchdog calls on public to report social media influencers failing to disclose posts as ads

Influencers who are in breach of the Australian Consumer Law can face penalties of up to $2.5m

The Guardian
Ancel·la SantosJan 21, 2023
Matthew RimmerJan 21, 2023

STOPAIDS and Global Health Advocates’ report series ‘Access Denied‘ explores how a lack of transparency in the pharmaceutical industry and the EU has harmed public health outcomes during the #COVID19 crisis

https://stopaids.org.uk/resources/access-denied-what-happens-when-big-pharma-is-in-the-drivers-seat/ #access2meds #EU #secrecy #transparency #contracts

Access Denied: What happens when Big Pharma is in the driver’s seat - STOPAIDS

STOPAIDS and Global Health Advocates’ report series ‘Access Denied‘ explores how a lack of transparency in the pharmaceutical industry and the EU has harmed public health outcomes. The series is structured into two reports. The first set the scene through speaking to key actors and stakeholders who were involved in or following the contract negotiations. In … Continued

STOPAIDS